223 related articles for article (PubMed ID: 7180579)
1. The quantitative liver function as measured by the galactose elimination capacity. I. Diagnostic value and relations to clinical, biochemical, and histological findings in patients with steatosis and patients with cirrhosis.
Lindskov J
Acta Med Scand; 1982; 212(5):295-302. PubMed ID: 7180579
[TBL] [Abstract][Full Text] [Related]
2. The quantitative liver function as measured by the galactose elimination capacity. II. Prognostic value and changes during disease in patients with cirrhosis.
Lindskov J
Acta Med Scand; 1982; 212(5):303-8. PubMed ID: 7180580
[TBL] [Abstract][Full Text] [Related]
3. Quantitative liver function tests as surrogate markers for end-points in controlled clinical trials: a retrospective feasibility study.
Lotterer E; Högel J; Gaus W; Fleig WE; Bircher J
Hepatology; 1997 Dec; 26(6):1426-33. PubMed ID: 9397982
[TBL] [Abstract][Full Text] [Related]
4. Urinary sodium balance in patients with cirrhosis: relationship to quantitative parameters of liver function.
Wensing G; Lotterer E; Link I; Hahn EG; Fleig WE
Hepatology; 1997 Nov; 26(5):1149-55. PubMed ID: 9362355
[TBL] [Abstract][Full Text] [Related]
5. [The galactose breath test. Modification of the method and comparison with galactose elimination capacity and plasma disappearance of bromsulphatein (author's transl)].
Grimm L; Bircher J; Preisig R
Z Gastroenterol; 1980 Jan; 18(1):45-56. PubMed ID: 7385933
[TBL] [Abstract][Full Text] [Related]
6. [Comparison of quantitative liver function tests to clinical, laboratory chemical and biopsy findings in patients with liver diseases].
Albers I; Hartmann H; Creutzfeldt W
Z Gastroenterol; 1988 Feb; 26(2):130-6. PubMed ID: 2577930
[TBL] [Abstract][Full Text] [Related]
7. Histologic abnormalities are common in protocol liver allograft biopsies from patients with normal liver function tests.
Abraham SC; Poterucha JJ; Rosen CB; Demetris AJ; Krasinskas AM
Am J Surg Pathol; 2008 Jul; 32(7):965-73. PubMed ID: 18460980
[TBL] [Abstract][Full Text] [Related]
8. [The oral galactose tolerance as a liver function test. Clinical-experimental studieson the prolem of dosage].
Rommel K; Grimmel K
Med Klin; 1967 Feb; 62(5):168-71. PubMed ID: 5590185
[No Abstract] [Full Text] [Related]
9. [Does serum HCV-RNA-positive hepatitis C differ from serum HCV-RNA-negative hepatitis C?].
Dällenbach A; Renner EL; Solioz M; Bianchi L; Schmid M; Reichen J
Schweiz Med Wochenschr; 1995 Oct; 125(40):1855-63. PubMed ID: 7481644
[TBL] [Abstract][Full Text] [Related]
10. [The prognostic value of the serial determination of galactose elimination capacity in chronic active hepatitis].
Aebli N; Reichen J
Schweiz Med Wochenschr; 1991 Jun; 121(26):970-6. PubMed ID: 1862313
[TBL] [Abstract][Full Text] [Related]
11. Effects of hyperglycemia on quantitative liver functions by the galactose load test in diabetic rats.
Young TH; Tang HS; Lee HS; Hsiong CH; Hu OY
Metabolism; 2007 Sep; 56(9):1265-9. PubMed ID: 17697871
[TBL] [Abstract][Full Text] [Related]
12. Aminopyrine breath test: development of a 13C-breath test for quantitative assessment of liver function in humans.
Mion F; Queneau PE; Rousseau M; Brazier JL; Paliard P; Minaire Y
Hepatogastroenterology; 1995; 42(6):931-8. PubMed ID: 8847048
[TBL] [Abstract][Full Text] [Related]
13. Albumin but not fibrinogen synthesis correlates with galactose elimination capacity in patients with cirrhosis of the liver.
Ballmer PE; Reichen J; McNurlan MA; Sterchi AB; Anderson SE; Garlick PJ
Hepatology; 1996 Jul; 24(1):53-9. PubMed ID: 8707282
[TBL] [Abstract][Full Text] [Related]
14. Development of nonalcoholic fatty liver disease after orthotopic liver transplantation for cryptogenic cirrhosis.
Contos MJ; Cales W; Sterling RK; Luketic VA; Shiffman ML; Mills AS; Fisher RA; Ham J; Sanyal AJ
Liver Transpl; 2001 Apr; 7(4):363-73. PubMed ID: 11303298
[TBL] [Abstract][Full Text] [Related]
15. Diagnostic value of antithrombin III and aminopyrine breath test in liver disease.
Rodzynek JJ; Preux C; Leautaud P; Abramovici J; Di Paolo A; Delcourt AA
Arch Intern Med; 1986 Apr; 146(4):677-80. PubMed ID: 3963948
[TBL] [Abstract][Full Text] [Related]
16. [Aspartate aminotransferase (AST) more than alanine aminotransferase (ALT) levels predict the progression of liver fibrosis in chronic HCV infection].
Stránský J; Ryzlová M; Striteský J; Horák J
Vnitr Lek; 2002 Oct; 48(10):924-8. PubMed ID: 16737138
[TBL] [Abstract][Full Text] [Related]
17. [Comparative laparoscopic, bioptic and clinical enzymological studies in liver cirrhosis and other chronic liver diseases].
Vradzhaliev ZH; Danev S
Vutr Boles; 1978; 17(2):8-17. PubMed ID: 148793
[TBL] [Abstract][Full Text] [Related]
18. Heparin elimination in patients with liver cirrhosis.
Teien AN
Thromb Haemost; 1977 Oct; 38(3):701-6. PubMed ID: 579516
[TBL] [Abstract][Full Text] [Related]
19. Decreased muscle strength in patients with alcoholic liver cirrhosis in relation to nutritional status, alcohol abstinence, liver function, and neuropathy.
Andersen H; Borre M; Jakobsen J; Andersen PH; Vilstrup H
Hepatology; 1998 May; 27(5):1200-6. PubMed ID: 9581671
[TBL] [Abstract][Full Text] [Related]
20. Impaired hepatic mitochondrial oxidation using the 13C-methionine breath test in patients with macrovesicular steatosis and patients with cirrhosis.
Spahr L; Negro F; Leandro G; Marinescu O; Goodman KJ; Rubbia-Brandt L; Jordan M; Hadengue A
Med Sci Monit; 2003 Jan; 9(1):CR6-11. PubMed ID: 12552242
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
